I have been fortunate to contribute to development of the technologies that shifted safety testing for the nation's blood supply to molecular testing and launched the APTIMA infectious disease molecular diagnostics platform, as well as, first-in-class genetic engineering programs for food, health and the environment.

Executed on multiple first-in-class advanced detection programs yielding FDA cleared CBER regulated blood screening and CDRH regulated medical diagnostics, including:

• First HIV, HCV, HBV, and West Nile Virus molecular screening tests for safety of US blood supply
• First FDA cleared combined Chlamydia/Gonorrhea amplified molecular test, eliminating the need for male genital swabbing using male/female urine specimens
• Read more about medical diagnostics platform and new product development experience

Tags: BIOTECHNOLOGY, NEW PRODUCT DEVELOPMENT